NewcelX Ltd.
NewcelX Ltd. (NCEL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NCEL · as of Jun 8, 2026
Key Statistics
Explore NewcelX Ltd. Data
ncel stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
ncel competitorsNCEL
BACK
BCTXW
CELU
CERO
KTTAStock Performance
Full HistoryAbout NewcelX Ltd.
NewcelX Ltd. a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovati…
what is newcelx ltd. · ncel stock overview · newcelx ltd. company profile · who is newcelx ltd. ceo · ncel NASDAQ · newcelx ltd. headquarters · newcelx ltd. business segments
About Stock Overview & Key Data
NewcelX Ltd. (NCEL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 24, 2025. As of the latest trading session, NCEL stock price is $3.24, with a market capitalization of $1.5M. The stock has returned -88.22% over the past 12 months and +70.53% year-to-date.
According to 2 Wall Street analysts, the consensus rating for NewcelX Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, NewcelX Ltd. reported revenue of — and net income of -$2.0M. For detailed data — including NewcelX Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NewcelX Ltd. (NCEL) stock price is $3.24. The stock is traded on NASDAQ under the ticker symbol NCEL. The 52-week range is $1.83 – $30.80.